Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0030111 | regulation of Wnt signaling pathway | 172/7229 | 363/18670 | 0.000426 | 0.004853 | 0.003451 | 172 | RABC46 | |
BP | GO:0006767 | water-soluble vitamin metabolic process | 50/7229 | 88/18670 | 0.0004287 | 0.004867 | 0.003461 | 50 | RABC46 | |
BP | GO:1903725 | regulation of phospholipid metabolic process | 50/7229 | 88/18670 | 0.0004287 | 0.004867 | 0.003461 | 50 | RABC46 | |
BP | GO:0001755 | neural crest cell migration | 35/7229 | 57/18670 | 0.0004313 | 0.004887 | 0.003476 | 35 | RABC46 | |
BP | GO:0061098 | positive regulation of protein tyrosine kinase activity | 34/7229 | 55/18670 | 0.000434 | 0.004904 | 0.003488 | 34 | RABC46 | |
BP | GO:0042471 | ear morphogenesis | 64/7229 | 118/18670 | 0.0004349 | 0.004904 | 0.003488 | 64 | RABC46 | |
BP | GO:0030195 | negative regulation of blood coagulation | 33/7229 | 53/18670 | 0.000435 | 0.004904 | 0.003488 | 33 | RABC46 | |
BP | GO:0007517 | muscle organ development | 192/7229 | 410/18670 | 0.000439 | 0.004938 | 0.003512 | 192 | RABC46 | |
BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 153/7229 | 319/18670 | 0.0004396 | 0.004938 | 0.003512 | 153 | RABC46 | |
BP | GO:0040013 | negative regulation of locomotion | 186/7229 | 396/18670 | 0.0004442 | 0.004981 | 0.003542 | 186 | RABC46 | |
BP | GO:0032091 | negative regulation of protein binding | 57/7229 | 103/18670 | 0.0004462 | 0.004995 | 0.003552 | 57 | RABC46 | |
BP | GO:1900180 | regulation of protein localization to nucleus | 63/7229 | 116/18670 | 0.0004576 | 0.005114 | 0.003637 | 63 | RABC46 | |
BP | GO:0050808 | synapse organization | 191/7229 | 408/18670 | 0.0004631 | 0.005167 | 0.003674 | 191 | RABC46 | |
BP | GO:0006643 | membrane lipid metabolic process | 104/7229 | 207/18670 | 0.0004646 | 0.005174 | 0.00368 | 104 | RABC46 | |
BP | GO:0032649 | regulation of interferon-gamma production | 56/7229 | 101/18670 | 0.0004676 | 0.005192 | 0.003693 | 56 | RABC46 | |
BP | GO:0072503 | cellular divalent inorganic cation homeostasis | 227/7229 | 493/18670 | 0.0004679 | 0.005192 | 0.003693 | 227 | RABC46 | |
BP | GO:0045446 | endothelial cell differentiation | 62/7229 | 114/18670 | 0.0004814 | 0.005329 | 0.00379 | 62 | RABC46 | |
BP | GO:0032637 | interleukin-8 production | 47/7229 | 82/18670 | 0.0004818 | 0.005329 | 0.00379 | 47 | RABC46 | |
BP | GO:0071236 | cellular response to antibiotic | 77/7229 | 147/18670 | 0.000509 | 0.005594 | 0.003978 | 77 | RABC46 | |
BP | GO:0001782 | B cell homeostasis | 21/7229 | 30/18670 | 0.0005092 | 0.005594 | 0.003978 | 21 | RABC46 | |
BP | GO:0050869 | negative regulation of B cell activation | 21/7229 | 30/18670 | 0.0005092 | 0.005594 | 0.003978 | 21 | RABC46 | |
BP | GO:0061082 | myeloid leukocyte cytokine production | 21/7229 | 30/18670 | 0.0005092 | 0.005594 | 0.003978 | 21 | RABC46 | |
BP | GO:0014706 | striated muscle tissue development | 183/7229 | 390/18670 | 0.000522 | 0.005725 | 0.004072 | 183 | RABC46 | |
BP | GO:0016101 | diterpenoid metabolic process | 60/7229 | 110/18670 | 0.0005324 | 0.005783 | 0.004113 | 60 | RABC46 | |
BP | GO:0061387 | regulation of extent of cell growth | 60/7229 | 110/18670 | 0.0005324 | 0.005783 | 0.004113 | 60 | RABC46 | |
BP | GO:0042063 | gliogenesis | 140/7229 | 290/18670 | 0.0005332 | 0.005783 | 0.004113 | 140 | RABC46 | |
BP | GO:0110020 | regulation of actomyosin structure organization | 53/7229 | 95/18670 | 0.0005367 | 0.005783 | 0.004113 | 53 | RABC46 | |
BP | GO:0061045 | negative regulation of wound healing | 44/7229 | 76/18670 | 0.0005367 | 0.005783 | 0.004113 | 44 | RABC46 | |
BP | GO:0001767 | establishment of lymphocyte polarity | 10/7229 | 11/18670 | 0.0005381 | 0.005783 | 0.004113 | 10 | RABC46 | |
BP | GO:0002604 | regulation of dendritic cell antigen processing and presentation | 10/7229 | 11/18670 | 0.0005381 | 0.005783 | 0.004113 | 10 | RABC46 |